Catalyst Wire Dossier Catalyst Wire Dossier

cis-UCA eye drops

cis-urocanic acid · Laurantis Pharma, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for cis-UCA eye drops, covering 2012-05-17 to 2012-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I) [Phase 1]

See pricing